New-onset atrial fibrillation in sepsis is associated with increased morbidity and mortality

Netherlands Heart Journal

Volumn 23, Issue 2, 2015, Pages 82-88

  Gandhi, Sumeet ^a,b   Litt, Dhanjit ^c,d   Narula, Neeraj ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b HAMILTON HEALTH SCIENCES   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Arrhythmia; Atrial fibrillation; Intensive care unit; Mortality; Sepsis

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; DISEASE ASSOCIATION; HEART ATRIUM FIBRILLATION; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; INTENSIVE CARE; LENGTH OF STAY; META ANALYSIS; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; REVIEW; RISK ASSESSMENT; RISK RATIO; SCORING SYSTEM; SENSITIVITY ANALYSIS; SEPSIS; SEPTIC SHOCK; SINUS RHYTHM; SYSTEMATIC REVIEW;

EID: 84922359759     PISSN: 15685888     EISSN: 18766250     Source Type: Journal    
DOI: 10.1007/s12471-014-0641-x     Document Type: Review

References (26)

1. Almassi GH, Schowalter T, Nicolosi AC, et al. Atrial fibrillation after cardiac surgery: a major morbid event? Ann Surg. 1997;226:501-11; discussion 511-03
2. Nattel S, Hadjis T, Talajic M. The treatment of atrial fibrillation. An evaluation of drug therapy, electrical modalities and therapeutic considerations. Drugs. 1994;48:345-71
3. Remick DG, Kunkel RG, Larrick JW, Kunkel SL. Acute in vivo effects of human recombinant tumor necrosis factor. Lab Invest. 1987;56:583-90
4. Tracey KJ, Beutler B, Lowry SF, et al. Shock and tissue injury induced by recombinant human cachectin. Science. 1986;234:470-4
5. Waage A, Halstensen A, Espevik T. Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet. 1987;1 (8529):355-7
6. Cunnion RE, Schaer GL, Parker MM, Natanson C, Parrillo JE. The coronary circulation in human septic shock. Circulation. 1986;73 (4):637-44
7. Dhainaut JF, Huyghebaert MF, Monsallier JF, et al. Coronary hemodynamics and myocardial metabolism of lactate, free fatty acids, glucose, and ketones in patients with septic shock. Circulation. 1987;75 (3):533-41
8. Kumar A, Thota V, Dee L, Olson J, Uretz E, Parrillo JE. Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med. 1996;183 (3):949-58
9. Allessie MA, Boyden PA, Camm AJ, et al. Pathophysiology and prevention of atrial fibrillation. Circulation. 2001;103 (5):769-77
10. Aoki Y, Hatakeyama N, Yamamoto S, et al. Role of ion channels in sepsis-induced atrial tachyarrhythmias in guinea pigs. Br J Pharmacol. 2012;166 (1):390-400
11. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327 (7414):557-60
12. Goodman S, Weiss Y, Weissman C. Update on cardiac arrhythmias in the ICU. Curr Opin Crit Care. 2008;14 (5):549-54
13. Seguin P, Launey Y. Atrial fibrillation is not just an artefact in the ICU. Crit Care. 2010;14 (4):182
14. Goss CH, Carson SS. Is severe sepsis associated with new-onset atrial fibrillation and stroke? JAMA. 2011;306 (20):2264-6
15. Lee-Iannotti JK, Capampangan DJ, Hoffman-Snyder C, et al. Newonset atrial fibrillation in severe sepsis and risk of stroke and death: a critically appraised topic. Neurologist. 2012;18 (4):239-43
16. Seguin P, Laviolle B, Maurice A, Leclercq C, Malledant Y. Atrial fibrillation in trauma patients requiring intensive care. Intensive Care Med. 2006;32 (3):398-404
17. Arora S, Lang I, Nayyar V, Stachowski E, Ross DL. Atrial fibrillation in a tertiary care multidisciplinary intensive care unit-incidence and risk factors. Anaesth Intensive Care. 2007;35 (5):707-13
18. Kindem IA, Reindal EK, Wester AL, Blaasaas KG, Atar D. Newonset atrial fibrillation in bacteremia is not associated with Creactive protein, but is an indicator of increased mortality during hospitalization. Cardiology. 2008;111 (3):171-80
19. Salman S, Bajwa A, Gajic O, Afessa B. Paroxysmal atrial fibrillation in critically ill patients with sepsis. J Intensive Care Med. 2008;23 (3):178-83
20. Christian SA, Schorr C, Ferchau L, Jarbrink ME, Parrillo JE, Gerber DR. Clinical characteristics and outcomes of septic patients with new-onset atrial fibrillation. J Crit Care. 2008;23 (4):532-6
21. Goodman S, Shirov T, Weissman C. Supraventricular arrhythmias in intensive care unit patients: short and long-term consequences. Anesth Analg. 2007;104 (4):880-886
22. Kumar GDA, Taneja A, Kumar N, et al. Atrial fibrillation is more frequent in patients with severe sepsis and septic shock predicts a worse outcome. Chest. 2010;138 (4_MeetingAbstracts):899A
23. Meierhenrich R, Steinhilber E, Eggermann C, et al. Incidence and prognostic impact of new-onset atrial fibrillation in patients with septic shock: a prospective observational study. Crit Care. 2010;14 (3):R108
24. Seguin P, Signouret T, Laviolle B, Branger B, Malledant Y. Incidence and risk factors of atrial fibrillation in a surgical intensive care unit. Crit Care Med. 2004;32 (3):722-726
25. Walkey AJ, Wiener RS, Ghobrial JM, Curtis LH, Benjamin EJ. Incident stroke and mortality associated with new-onset atrial fibrillation in patients hospitalized with severe sepsis. JAMA. 2011;306 (20):2248-54
26. Wells GL, Morris PE. Incidence and prognosis of atrial fibrillation in patients with sepsis. Cardiol Res. 2011;2 (6):293-7